Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter March 9, 2017

Ethnopharmacological approaches in mood and anxiety disorders. The relevance of the oxidative stress status

  • Simplice Harquin Foyet , Ioana-Miruna Balmus , Ngatanko Abaïssou Hervé Hervé , Asongalem Acha Emmanuel , Samson Guenne , Martin Kiendrebéogo and Alin Ciobica EMAIL logo


Neurodegenerative diseases and psychiatric disorders are one of the most important pathologies that lead to increased morbidity in populations. Both mood and anxiety disorders include mental disorders not caused by detectable organic abnormalities of the brain. At the molecular level, affective spectrum symptomatology is due to neurotransmitter dysregulation including receptor or transporter impairments and also due to faulty intracellular signaling that generally leads to impaired neurotransmission. Also, recent studies have shown the relationship between oxidative stress and the development of affective disorders. Since classical medication can cause major side effects and alternative approaches tend to be more and more trusted, it seems that plant extracts-based complementary therapies may offer superior yielding and safety compared to traditional medication.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Ioana-Miruna Balmus was co-funded by the European Social Fund through Sectorial Operational Program of Human Resources Development 2007 – 2013, project number POSDRU/187/1.5/S/155397, project title “Towards a New Generation of Elite Researchers through Doctoral Scholarships” during the work for this review. Ciobica Alin and Miruna Balmus are supported by a PN II Research Grant no. PN-II-RU-TE-2014-4-1886, called “A Complex Study regarding the Relevance of Oxytocin Administration in Some Animal Models of Neuropsychiatric Disorders.”

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


1. Mohamed I, Shuid A, Borhanuddin H, Fozi N. The application of phytomedicine in modern drug development. Int J Herb Plant Med. 2012;1:1–9.Search in Google Scholar

2. Payyappallimana U. Role of traditional medicine in primary health care: an overview of perspectives and challenges. Yokohama J Soc Sci. 2010;14:57–77.Search in Google Scholar

3. Pilania M, Bairwa M, Kumar N, Khanna P, Kurana H. Elderly depression in India: an emerging public health challenge. Australas Med J. 2013;6:107–111.10.4066/AMJ.2013.1583Search in Google Scholar PubMed PubMed Central

4. World Health Organization. Neurological disorders affect millions globally report. Brussels/Geneva: World Health Organization, 2007.Search in Google Scholar

5. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2007;62:617–627.10.1001/archpsyc.62.6.617Search in Google Scholar PubMed PubMed Central

6. Sobocki P, Jönsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9:87–98.Search in Google Scholar

7. Sylvie DD, Pieme CA, Biapa PC, Penlap BV. Comparison of in vitro antioxidant properties of extracts from three plants used for medical purpose in Cameroon: Acalypha racemosa, Garcinia lucida and Hymenocardia lyrata. Asian Pac J Trop Biomed. 2014;4–2 . S625–S632.10.12980/APJTB.4.201414B168Search in Google Scholar

8. Xu Y, Wang C, Klabnik JJ, O’Donnell JM. Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment. Cur Neuropharmacol. 2014;12:108–119.10.2174/1570159X11666131120231448Search in Google Scholar PubMed PubMed Central

9. Trebatická J, Ďuračková Z. Psychiatric disorders and polyphenols: Can they be helpful in therapy?. Oxid Med Cell Longev. 2005;248529.10.1155/2015/248529Search in Google Scholar PubMed PubMed Central

10. Halliwell B, Lee CY. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid Redox Signaling. 2010;13:145–156.10.1089/ars.2009.2934Search in Google Scholar PubMed

11. Halliwell B. Free radicals and antioxidants – quo vadis?. Trends Pharmacol Sci. 2011;32:125–130.10.1016/ in Google Scholar PubMed

12. Hovatta I, Juhila J, Donner J. Oxidative stress in anxiety and comorbid disorders. Neurosci Res. 2010;68:261–27.10.1016/j.neures.2010.08.007Search in Google Scholar PubMed

13. Akiskal HS. Mood disorders: clinical features. In: Kaplan HI, Sadock BJ, Sadock VA, editors. Kaplan & Sadock’s comprehensive textbook of psychiatry. Philadelphia, PA: Wolters Kluwer: Lippincott Williams & Wilkins, 2004:1.Search in Google Scholar

14. Wilhelm K, Roy K. Gender differences in depression risk and coping factors in a clinical sample. Acta Psychiatr Scandinav. 2003;106:45–53.10.1034/j.1600-0447.2002.02094.xSearch in Google Scholar PubMed

15. Fišar K, Hroudová J, Raboch J. Neurotransmission in mood disorders. In: Juruena MF, editors. Clinical research and treatment approaches to affective disorders. Rijeka: InTechOpen, 2012:47.Search in Google Scholar

16. Evans DL, Charney DS, Lewis IL, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005;58:175–189.10.1016/j.biopsych.2005.05.001Search in Google Scholar PubMed

17. Li X, Frye MA, Shelton RC. Mood disorders. Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmacol Rev. 2012;37:77–101.10.1038/npp.2011.198Search in Google Scholar

18. Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2003;14:609–625.10.1038/nrn3381Search in Google Scholar

19. Angst J, Ajdacic-Gross V, Rössler W. Classification of mood disorders. Psychiatr Pol. 2015;49:663–671.10.12740/PP/58259Search in Google Scholar

20. Chang CC, Jou SH, Lin TT, Lai TT, Liu CS. Mitochondria DNA change and oxidative damage in clinically stable patients with major depressive disorder. Plos One. 2015;10:0125855.10.1371/journal.pone.0125855Search in Google Scholar

21. Vaváková M, Ďuračková Z, Trebatická J. Markers of oxidative stress and neuroprogression in depression disorder. Oxid Med Cell Longev 2015 . ID 898393.10.1155/2015/898393Search in Google Scholar

22. Silva MCC, De Sousa CNS, Gomes PXL, De Oliveira GV, Araújo FYR, Ximenes NC, et al. Evidence for protective effect of lipoic acid and desvenlafaxine on oxidative stress in a model depression in mice. Prog Neuro-Psychopharmacol Biol Psych. 2016;64:142–148.10.1016/j.pnpbp.2015.08.002Search in Google Scholar

23. Fuchs E, Flügge G. Adult neuroplasticity: more than 40 years of research. Neural Plast. 2014;541870.10.1155/2014/541870Search in Google Scholar

24. Ditzen C, Jastorff AM, Keßler MS, Bunck M, Teplytska L, Erhardt A, et al. Protein biomarkers in a mouse model of extremes in trait anxiety. Mol Cell Proteomics. 2006;5:1914–1920.10.1074/mcp.M600088-MCP200Search in Google Scholar

25. Siwek M, Sowa-Kuæma M, Dudek D, Styczeñ K, Szewczyk B, Kotarska K, et al. Oxidative stress markers in affective disorders. Pharmacol Rep. 2013;65:1558–1571.10.1016/S1734-1140(13)71517-2Search in Google Scholar

26. Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies. CNS Drugs. 2013;27:207–219.10.1007/s40263-013-0044-3Search in Google Scholar PubMed

27. Ďuračková Z. Some current insights into oxidative stress. Physiol Res. 2010;59:459–469.10.33549/physiolres.931844Search in Google Scholar PubMed

28. Salim S. Oxidative stress and psychological disorders. Cur Neuropharmacol. 2014;12:140–147.10.2174/1570159X11666131120230309Search in Google Scholar PubMed PubMed Central

29. Luca M, Luca A, Calandra C. Accelerated aging in major depression: the role of nitro-oxidative stress. Oxid Med Cell Longev 2013 . ID 230797.10.1155/2013/230797Search in Google Scholar PubMed PubMed Central

30. Gautam M, Agrawal M, Gautam M, Sharma A, Gautam A, Gautam M. Role of antioxidants in generalised anxiety disorder and depression. Indian J Psychiatry. 2012;54:244–247.10.4103/0019-5545.102424Search in Google Scholar PubMed PubMed Central

31. Bulut M, Selek S, Bez Y, Karababa YA, Kaya MC, et al. Reduced PON1 enzymatic activity and increased lipid hydroperoxide levels that point out oxidative stress in generalized anxiety disorder. J Affect Disord. 2013;150:829–833.10.1016/j.jad.2013.03.011Search in Google Scholar PubMed

32. Bouayed J, Rammal H, Younos C, Soulimani R. Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety in mice. Eur J Pharmacol. 2007;564:146–149.10.1016/j.ejphar.2007.02.055Search in Google Scholar PubMed

33. Masood A, Nadeem A, Mustafa SJ, O’Donnell JM. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther. 2008;326:369–379.10.1124/jpet.108.137208Search in Google Scholar PubMed PubMed Central

34. Ranjana SK, Reena N, Deepti P, Shruti K, Hari KD. Markers of oxidative stress in generalized anxiety psychiatric disorder: therapeutic implications. J Stress Physiol Biochem. 2012;8:32–38.Search in Google Scholar

35. Hassan W, Silva CEB, Mohammadzai IU, Da Rocha JTB, Landeira-Fernandez J. Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions. Cur Neuropharmacol. 2014;12:120–139.10.2174/1570159X11666131120232135Search in Google Scholar PubMed PubMed Central

36. Berry A, Capone F, Giorgio M, Pelicci PG, De Kloet ER, Alleva E, et al. Deletion of the life span determinant p66Shc prevents age-dependent increases in emotionality and pain sensitivity in mice. Exp Gerontol. 2007;42:37–45.10.1016/j.exger.2006.05.018Search in Google Scholar PubMed

37. Ersoy M, Salek K, Celik H, Erel O, Kaya MC, Savas HA. Role of oxidative and antioxidative parameters in ethiopathogenesis and prognosis of panic disorder. Int J Neurosci. 2008;118:1025–1037.10.1080/00207450701769026Search in Google Scholar PubMed

38. Cengiz M, Bayoglu B, Alansal NO, Cengiz S, Dirican A, Kocabasoglu N. Pro198Leu polymorphism in the oxidative stress gene, glutathione peroxidase-1, is associated with a gender-specific risk for panic disorder. Int J Psychiatry Clin Pract. 2015;2:1–7.10.3109/13651501.2015.1016973Search in Google Scholar PubMed

39. Lissemore JI, Leyton M, Gravel P, Sookman D, Nordahl TE, Benkelfat C PET and SPECT in Psychiatry. In: Rajo D, et al., editors. OCD: Serotonergic mechanisms. Berlin: Springer, 2014:433–450.Search in Google Scholar

40. Orhan N, Kucukali CI, Cakir U, Seker N, Aydin M. Genetic variants in nuclearencoded mitochondrial proteins are associated with oxidative stress in obsessive compulsive disorders. J Psychiat Res. 2012;46:212e8.10.1016/j.jpsychires.2011.09.012Search in Google Scholar PubMed

41. Behl A, Swami G, Sircar SS, Bhatia MS, Banerjee BD. Relationship of possible stress related biochemical markers to oxidative/antioxidative status in obsessive compulsive disorder. Neuropsychobiology. 2010;61:210e4.10.1159/000306591Search in Google Scholar PubMed

42. Selek S, Herken H, Bulut M, Ceylan MF, Celik H, Savas HA, et al. Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidantantioxidant status. Prog Neuro-Psychopharmacol Biol Psych. 2008;32:487e91.10.1016/j.pnpbp.2007.10.002Search in Google Scholar PubMed

43. Kandemir H, Abuhandan M, Aksoy N, Savik E, Kaya C. Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder. J Psychiatr Res. 2013;47:1831e1834.10.1016/j.jpsychires.2013.08.010Search in Google Scholar PubMed

44. Krolow R, Arcego DM, Noschang C, Weis SN, Dalmaz C. Oxidative imbalance and anxiety disorders. Cur Neuropharmacol. 2014;12:193–204.10.2174/1570159X11666131120223530Search in Google Scholar PubMed PubMed Central

45. Martin A, Chalder T, Rief W, Braehler E. The relationship between chronic fatigue and somatization syndrome: a general population survey. J Psychosom Res. 2007;63:147–156.10.1016/j.jpsychores.2007.05.007Search in Google Scholar PubMed

46. Sindhi V, Gupta V, Sharma K, Bhatnagar S, Kumari R, Dhaka N. Potential applications of antioxidants. A review. J Pharm Res. 2013;7:828–835.10.1016/j.jopr.2013.10.001Search in Google Scholar

47. Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, Hensley K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis. 2008;15:473–493.10.3233/JAD-2008-15314Search in Google Scholar PubMed PubMed Central

48. Li X, Deng J, Shen S, Li T, Yuan M, Yang R, et al. Antioxidant activities and functional properties of enzymatic protein hydrolysates from defatted Camellia oleifera seed cake. J Food Sci Technol. 2015;52:5681–5690.10.1007/s13197-014-1693-zSearch in Google Scholar PubMed PubMed Central

49. Mut-Salud N, Álvarez PJ, Garrido JM, Carrasco E, Aránega A, Rodríguez-Serrano F. Antioxidant intake and antitumor therapy: toward nutritional recommendations for optimal results. Oxid Med Cell Longev. 2016;6719534.10.1155/2016/6719534Search in Google Scholar PubMed PubMed Central

50. Foyet HS, Hritcu L, Ciobica A, Stefan M, Kamtchouing P, Cojocaru D. Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease. J Ethnopharmacol. 2011;133:773–779.10.1016/j.jep.2010.11.011Search in Google Scholar PubMed

51. Hritcu L, Ciobica A, Artenie V. Effects of right-unilateral 6-hydroxydopamine infusion-induced memory impairment and oxidative stress: relevance for Parkinson’s disease. Cent Eur J Biol. 2008;3:250–257.10.2478/s11535-008-0023-8Search in Google Scholar

52. Foyet HS, Tsala DE, Bouba AA, Hritcu L. Anxiolytic and antidepressant-like effects of the aqueous extract of Alafia multiflora stem barks in rodents. Adv Pharmacol Sci 2012 . ID 912041.10.1155/2012/912041Search in Google Scholar PubMed PubMed Central

53. Foyet HS, Ngatanko Abaïssou HH, Wado E, Asongalem Acha E, Ciobica A. Emilia coccinea (SIMS) G extract improves memory impairment, cholinergic dysfunction, and oxidative stress damage in scopolamine-treated rats. BMC Complement Altern Med. 2015;15:333.10.1186/s12906-015-0864-4Search in Google Scholar PubMed PubMed Central

54. Crupi R, Mazzon E, Marino A, La Spada G, Bramanti P, Battaglia F, et al. Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice. BMC Complement Altern Med. 2011;11:7.10.1186/1472-6882-11-7Search in Google Scholar PubMed PubMed Central

55. Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine. 2006;13:607–611.10.1016/j.phymed.2006.08.006Search in Google Scholar PubMed

56. Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011;21:841–860.10.1016/j.euroneuro.2011.04.002Search in Google Scholar PubMed

57. Pereira RP, Fachinetto R, De Souza Prestes A, Puntel RL, Santos Da Silva GN, Heinzmann BM, et al. Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. Neurochem Res. 2009;34:973–983.10.1007/s11064-008-9861-zSearch in Google Scholar PubMed

58. Singh V, Singh PS, Chan K. Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia. Int J Neuropsychopharmacol. 2010;13:257–271.10.1017/S1461145709990654Search in Google Scholar PubMed

59. Lohani M, Ahuja M, Buabeid MA, Dean S, Dennis S, Suppiramaniam V, et al. Anti-oxidative and DNA protecting effects of flavonoids-rich Scutellaria lateriflora. Nat Prod Commun. 2013;8:1415–1418.10.1177/1934578X1300801019Search in Google Scholar

60. Sayyah M, Boostani H, Pakseresht S, Malayeri A. Comparison of Silybum marianum (L) Gertn with fluoxetine in the treatment of obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psych. 2010;34:362–365.10.1016/j.pnpbp.2009.12.016Search in Google Scholar

61. Herman H, Pilat L, Mihali C, Popescu C, Turcus V, Ardelean A, et al. Pharmacology of Silybum marianum and its active constituents. Therapeutic activity – Part 2. Arad Med J. 2011;14:35–40.Search in Google Scholar

62. Elsas SM, Rossi DJ, Raber J, White G, Seeley CA, Gregory WL, et al. Passiflora incarnata L. (Passion flower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine. 2010;17:940–949.10.1016/j.phymed.2010.03.002Search in Google Scholar

63. Chen Y, Han T, Qin L, Rui Y, Zheng H. Effect of total triterpenes from Centella asiatica on the depression behavior and concentration of amino acid in forced swimming mice. Zhong Yao Cai. 2003;26:870–873.Search in Google Scholar

64. Sepand MR, Soodi M, Hajimehdipoor H, Soleimani H, Sahraei E. Comparison of neuroprotective effects of Melissa officinalis total extract and its acidic and non-acidic fractions against A β-induced toxicity. Iran J Pharmacol Res. 2013;12:415–423.Search in Google Scholar

65. Ranjbar A, Khorami S, Safarabadi M, Shahmoradi A, Malekirad AA, Vakilian K, et al. Antioxidant activity of Iranian Echium amoenum fisch & C.A. Mey flower decoction in humans: a cross-sectional before/after clinical trial. Evid Based Complement Alternat Med. 2006;3:469–473.10.1093/ecam/nel031Search in Google Scholar

66. Joshi YB, Praticò D. Lipid peroxidation in psychiatric illness: overview of clinical evidence. Oxid Med Cell Longev 2014 . ID 828702.10.1155/2014/828702Search in Google Scholar

67. Erdem M, Akarsu S, Pan E, Kurt YG. Bipolar disorder and oxidative stress. Jmood. 2014;4:70–79.10.5455/jmood.20131205063815Search in Google Scholar

68. Liu T, Zhong S, Liao X, Chen J, He T, et al. A meta-analysis of oxidative stress markers in depression. Plos One. 2015;10:0138904.10.1371/journal.pone.0138904Search in Google Scholar

69. Thomas SP, Nandhra HS, Jayaraman A. Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD). J Ment Health. 2010;19:168–175.10.3109/09638230903469269Search in Google Scholar

70. Malhi GS, Tanious M, Das P, Coulston CM, Berk M. Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs. 2013;27:135–153.10.1007/s40263-013-0039-0Search in Google Scholar

71. Takeda H, Tsuji M, Inazu M, Egashira T, Matsumiya T. Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice. Eur J Pharmacol. 2002;449:261–267.10.1016/S0014-2999(02)02037-XSearch in Google Scholar

72. Hritcu L, Foyet HS, Stefan M, Mihasan M, Asongalem AE, Kamtchouing P. Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. J Ethnopharmacol. 2011;137:585–591.10.1016/j.jep.2011.06.008Search in Google Scholar PubMed

73. Oboh G, Rocha JBT. Antioxidant and neuroprotective properties of sour tea (Hibiscus sabdariffa, calyx) and green tea (Camellia sinensis) on some pro-oxidant-induced lipid peroxidation in brain in vitro. Food Biophys. 2008;3:382–389.10.1007/s11483-008-9092-5Search in Google Scholar

74. Nade VS, Kanhere SV, Kawale LA, Yadav AV. Cognitive enhancing and antioxidant activity of ethyl acetate soluble fraction of the methanol extract of Hibiscus rosa sinensis in scopolamine induced amnesia. Indian Pharmacol. 2011;43:137–142.10.4103/0253-7613.77347Search in Google Scholar PubMed PubMed Central

75. Foyet HS, Tsala DE, Ngatanko AH. Enhancing spatial memory: anxiolytic and antidepressant effects of Tapinanthus dodoneifolius (DC) Danser in mice. Neurol Res Int. 2014;974308.10.1155/2014/974308Search in Google Scholar PubMed PubMed Central

76. Hritcu L, Noumedem JA, Cioanca O, Hancianu M, Postu P, Mihasan M. Anxiolytic and antidepressant profile of the methanolic extract of Piper nigrum fruits in beta-amyloid (1-42) rat model of Alzheimer’s disease. Behav Brain Funct. 2015;11:13.10.1186/s12993-015-0059-7Search in Google Scholar PubMed PubMed Central

77. Hritcu L, Cioanca O, Hancianu M. Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine. 2012;19:529–534.10.1016/j.phymed.2012.02.002Search in Google Scholar PubMed

78. Cioanca O, Hritcu L, Mihasan M, Trifan A, Hancianu M. Inhalation of coriander volatile oil increased anxiolytic-antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1-42) rat model of Alzheimer’s disease. Physiol Behav. 2014;131:68–74.10.1016/j.physbeh.2014.04.021Search in Google Scholar PubMed

79. Tsala DE, Theophile D, Judith N, Ng N, Penlap BV, Boda M, et al. Screening of Alafia multiflora for antibacterial, antiradical activity and LD50 investigation. Int J Pharmacol. 2007;3:327–333.10.3923/ijp.2007.327.333Search in Google Scholar

80. Halliwell B. Reactive species and antioxidants. redox biology is a fundamental theme of aerobic life. Plant Physiol. 2006;141:312–322.10.1104/pp.106.077073Search in Google Scholar PubMed PubMed Central

81. Berk M, Ng F, Dean O, Dodd S, Bush AI. Glutahione: a novel treatment target in psychiatry. Trends Pharmacol Sci. 2008;29:346–351.10.1016/ in Google Scholar PubMed

82. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11:1–26.10.1017/S1461145707008401Search in Google Scholar PubMed

83. Pillai A. Brain-derived neurotrophic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia. Neurosignals. 2008;16:183–193.10.1159/000111562Search in Google Scholar PubMed

84. Nemeroff CB, Goldschmidt-Clermont PJ. Heartache and heartbreak-the link between depression and cardiovascular disease. Nat Rev Cardiol. 2012;9:526–539.10.1038/nrcardio.2012.91Search in Google Scholar PubMed

85. Foyet HS, Abdou BA, Ngatanko AH, Manyi FL, Manyo NA, Shu NPN, et al. Neuroprotective and memory improvement effects of a standardized extract of Emilia coccinea (SIMS) G on animal models of anxiety and depression. J Pharmacogn Phytochem. 2014;3:146–154.Search in Google Scholar

Received: 2016-6-19
Accepted: 2017-1-24
Published Online: 2017-3-9
Published in Print: 2017-3-8

© 2017 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 28.11.2023 from
Scroll to top button